ストックスクリーナーアプリを入手
4.3248
3.15%
-0.1252
前日終値:
$4.45
開ける：
$4.15
24時間の取引高:
41,233
Relative Volume:
5.08
時価総額：
$200.51M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.10%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.15
$4.42
1週間の範囲:
$4.15
$4.8816
52週間の値動き範囲:
$4.15
$4.8816
Capsovision Inc Stock (CV) Company Profile
CV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
4.35 | 202.52M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.19 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.62 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.53 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.47 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.31 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Capsovision Inc (CV) 最新ニュース
CapsoVision enters development agreement with Canon and announces partial IPO overallotment exercise - Investing.com South Africa
CapsoVision Raises $600,000 Through IPO Overallotment - TipRanks
CapsoVision prices $27.5M IPO - MSN
Why Did CapsoVision Plunge 10.45% After IPO Pricing? - AInvest
CapsoVision's IPO: A Pill to Swallow in the GI Diagnostics Market? - AInvest
CapsoVision Soars 40.31% on IPO Debut - AInvest
CapsoVision Closes $27.5 Million IPO; Shares Rebound - MarketScreener
CapsoVision, Inc. Successfully Closes Initial Public Offering Raising $27.5 Million - Nasdaq
CapsoVision Announces Closing of Initial Public Offering - GlobeNewswire
CapsoVision Stocks: Bursting Bubbles or Rising Stars? - StocksToTrade
CapsoVision’s Wild Ride: Why This Med-Tech Newcomer Is Turning Heads on Nasdaq - RagingBull
CapsoVision’s Rollercoaster: Risk or Reward? - timothysykes.com
CapsoVision, Inc.(NasdaqCM: CV) added to NASDAQ Composite Index - MarketScreener
CapsoVision begins trading on Nasdaq at $5 per share, declines since - Investing.com India
CV IPO NewsMedical device maker CapsoVision prices IPO at $5, the low end of the range - renaissancecapital.com
CapsoVision Prices 5.5M Share IPO at $5/sh - Investing.com Australia
CapsoVision Prices IPO at $5 per Share - MarketScreener
CapsoVision, Inc. Announces Initial Public Offering Pricing of $5.00 per Share - Nasdaq
Med-tech IPOs gain steam going into Q3 - BioWorld MedTech
CapsoVision Aims to Swallow GI Imaging Market – $28M Nasdaq Debut Eyes AI-Powered Diagnostic Future - Minichart
CapsoVision, Inc. (CV) Announces July 2nd IPO - Defense World
CapsoVision IPO: Key Details and Insights into the Company’s Market Debut - AInvest
Caris settles IPO at $21, trading starts at $28 - BioWorld MedTech
CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology (Pending:CV) - Seeking Alpha
Three med-tech IPOs on the horizon - BioWorld MedTech
Capsule endoscopy developer CapsoVision files $30M IPO - Fierce Biotech
CapsoVision Inc’s IPO: A Groundbreaking Play in Medical Imaging? - AInvest
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Earns FDA Clearance to Continue Remote Ingestion, Further Expanding Access and Comfort for Patients - The Malaysian Reserve
CapsoVision's CapsoCam Plus® Capsule Endoscopy System Receives FDA Clearance for Pediatric Use, Offering a Comfortable, Child-Friendly Solution for Young Patients - PR Newswire
Global Smart Pills Technologies Industry is poised for a substantial surge, targeting US$ 6176 Milli - PharmiWeb.com
Capsule Endoscopes Market Size (2022-2030)Advin Healthcare, CapsoVision Inc, Fujifilm Holding Corporation, Koninklijke Philips NV, Medtronic Plc and Olympus Corporation - Yahoo Finance
CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19 - PR Newswire
Ingestible Sensors Market Is Likely to Experience a Tremendous - openPR.com
CapsoVision Announces U.S. Distribution Partnership With PENTAX Medical - GlobeNewswire
UPDATE -- CapsoVision, Inc. Announces CE Mark for the Use - GlobeNewswire
CapsoVision Enhances CapsoCam Plus Capsule Endoscopy System With CapsoCloud - Medical Design & Outsourcing
CapsoVision, Inc. Announces FDA 510(k) Clearance For CapsoCam Plus - Med Device Online
Capsovision Inc (CV) 財務データ
Capsovision Inc (CV) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.21%
0.22%
大文字化:
|
ボリューム (24 時間):